Methods to treat one or all of the defined etiologies of female sexual dysfunction
    1.
    发明申请
    Methods to treat one or all of the defined etiologies of female sexual dysfunction 审中-公开
    治疗女性性功能障碍的一个或所有定义病因的方法

    公开(公告)号:US20050245494A1

    公开(公告)日:2005-11-03

    申请号:US11176546

    申请日:2005-07-07

    摘要: The U.S. Food and Drug Administration defines the four separate components of Female Sexual Dysfunction (FSD) to be decreased sexual desire, decreased sexual arousal, dyspareunia (pain with intercourse), and persistent difficulty in achieving or inability to achieve orgasm (anorgasmia). To establish a diagnosis of FSD, these components must be associated with personal distress, as determined by the affected woman. A topical combination of menthol/L-arginine and the specific 5-PDE inhibitor vardenafil can be used to treat any of the defined components, or a combination of two or more of the defined components of FSD, as a safe, first-line therapy for FSD.

    摘要翻译: 美国食品和药物管理局定义了女性性功能障碍(FSD)的四个不同组成部分,即性欲降低,性唤醒减轻,性交疼痛(性交疼痛),以及实现或无法达到性高潮(anorgasmia)的持续困难。 要确定消防处的诊断,这些部件必须与受影响的妇女确定的个人遇险有关。 薄荷醇/ L-精氨酸和特定的5-PDE抑制剂伐地那非的局部组合可用于治疗任何限定的组分,或两种或更多种定义的FSD组分的组合,作为安全的一线治疗 为FSD。

    Vagal nerve bulking arrangement
    7.
    发明申请
    Vagal nerve bulking arrangement 审中-公开
    迷走神经膨胀排列

    公开(公告)号:US20060025808A1

    公开(公告)日:2006-02-02

    申请号:US11165075

    申请日:2005-06-22

    IPC分类号: A61B17/00

    摘要: A method for the appetite suppression of an individual comprising the steps of introducing a bulking material between the vagal nerve area and the stomach wall of a patient undergoing appetite suppression treatment to reduce production levels of ghrelin in the patient's system.

    摘要翻译: 一种用于个体食欲抑制的方法,包括以下步骤:在经历食欲抑制治疗的患者的迷走神经区域和胃壁之间引入膨胀材料以降低患者系统中生长素释放肽的产生水平。

    Shoe
    8.
    外观设计
    Shoe 有权

    公开(公告)号:USD899038S1

    公开(公告)日:2020-10-20

    申请号:US29653099

    申请日:2018-06-12

    申请人: James Thompson

    设计人: James Thompson